This report describes general characteristics of the group of diseases classified as myofibrillar myopathy (MFM). Myofibrillar myopathy is a genetically heterogeneous disorder, with multiple genes and mapped loci. A comprehensive list of MFM subtypes, as defined by OMIM, can be found by following the link in the "OMIM phenotypic series" sub-section of the "Related Diseases" section, below. The accompanying table links to more detailed reports for subtypes that have been investigated using fly models.
[updated Aug. 2017 by FlyBase; FBrf0222196]
Myofibrillar myopathy is characterized by slowly progressive weakness that can involve both proximal and distal muscles. Distal muscle weakness is present in about 80% of individuals and is more pronounced than proximal weakness in about 25%. A minority of individuals experience sensory symptoms, muscle stiffness, aching, or cramps. Peripheral neuropathy is present in about 20% of affected individuals. Overt cardiomyopathy is present in 15%-30%. [from Gene Reviews, Myofibrillar Myopathy; 2017.08.14]
Myofibrillar myopathy (MFM) is a noncommittal term that refers to a group of morphologically homogeneous, but genetically heterogeneous chronic neuromuscular disorders. [from MIM:601419; 2017.08.14]
Several of the genes implicated in myofibrillar myopathy are also implicated in types of muscular dystrophy. [from Gene Reviews, Myofibrillar Myopathy; 2017.08.14]
The morphologic changes in skeletal muscle in MFM result from disintegration of the sarcomeric Z disc and the myofibrils, followed by abnormal ectopic accumulation of multiple proteins involved in the structure of the Z disc, including desmin, alpha-B-crystallin, dystrophin, and myotilin. [from MIM:601419; 2017.08.14]